These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26277622)

  • 1. BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine.
    Kannan S; Kurupati RK; Doyle SA; Freeman GJ; Schmader KE; Ertl HC
    Oncotarget; 2015 Aug; 6(23):19445-55. PubMed ID: 26277622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies.
    Faenzi E; Zedda L; Bardelli M; Spensieri F; Borgogni E; Volpini G; Buricchi F; Pasini FL; Capecchi PL; Montanaro F; Belli R; Lattanzi M; Piccirella S; Montomoli E; Ahmed SS; Rappuoli R; Del Giudice G; Finco O; Castellino F; Galli G
    Vaccine; 2012 Jun; 30(27):4086-94. PubMed ID: 22521851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood.
    Kurupati R; Kossenkov A; Haut L; Kannan S; Xiang Z; Li Y; Doyle S; Liu Q; Schmader K; Showe L; Ertl H
    Oncotarget; 2016 Sep; 7(39):62898-62911. PubMed ID: 27588486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The generation of memory B cells is maintained, but the antibody response is not, in the elderly after repeated influenza immunizations.
    Frasca D; Diaz A; Romero M; Blomberg BB
    Vaccine; 2016 May; 34(25):2834-40. PubMed ID: 27108193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of activation marker CD69 and chemokine receptors CCR5 and CXCR3 on memory T cells after 2009 H1N1 influenza A antigen stimulation in vitro following H1N1 vaccination of HIV-infected individuals.
    Chawansuntati K; Chotirosniramit N; Sugandhavesa P; Aurpibul L; Thetket S; Kosashunhanan N; Supindham T; Kaewthip O; Sroysuwan P; Sirisanthana T; Suparatpinyo K; Wipasa J
    Hum Vaccin Immunother; 2015; 11(9):2253-65. PubMed ID: 26091502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets.
    Cherukuri A; Servat E; Woo J
    Vaccine; 2012 Jan; 30(2):237-46. PubMed ID: 22080173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50- to 74-year-old adults.
    Kennedy RB; Simon WL; Gibson MJ; Goergen KM; Grill DE; Oberg AL; Poland GA
    Immunology; 2016 Jul; 148(3):266-75. PubMed ID: 27188667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.
    Sasaki S; Jaimes MC; Holmes TH; Dekker CL; Mahmood K; Kemble GW; Arvin AM; Greenberg HB
    J Virol; 2007 Jan; 81(1):215-28. PubMed ID: 17050593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of preexisting memory to seasonal A/H1N1 influenza virus on the immune response following vaccination against avian A/H5N1 virus.
    Buricchi F; Bardelli M; Malzone C; Capecchi B; Nicolay U; Fragapane E; Castellino F; Del Giudice G; Galli G; Finco O
    Eur J Immunol; 2013 Mar; 43(3):641-8. PubMed ID: 23238926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains.
    Lee VJ; Tay JK; Chen MI; Phoon MC; Xie ML; Wu Y; Lee CX; Yap J; Sakharkar KR; Sakharkar MK; Lin RT; Cui L; Kelly PM; Leo YS; Tan YJ; Chow VT
    Vaccine; 2010 Oct; 28(42):6852-7. PubMed ID: 20723626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials.
    Peeters M; Regner S; Vaman T; Devaster JM; Rombo L
    Vaccine; 2012 Oct; 30(45):6483-91. PubMed ID: 22885014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.
    Rinaldi S; Zangari P; Cotugno N; Manno EC; Brolatti N; Castrucci MR; Donatelli I; Rossi P; Palma P; Cagigi A
    Vaccine; 2014 Feb; 32(6):657-63. PubMed ID: 24333344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine.
    Frasca D; Diaz A; Romero M; Landin AM; Blomberg BB
    Vaccine; 2015 Mar; 33(12):1433-9. PubMed ID: 25659271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A(H1N1)pdm09 vaccination of health care workers: improved immune responses in low responders following revaccination.
    Pathirana RD; Bredholt G; Akselsen PE; Pedersen GK; Cox RJ
    J Infect Dis; 2012 Dec; 206(11):1660-9. PubMed ID: 22969149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a 2009 pandemic influenza virus A H1N1 vaccine, administered simultaneously with the seasonal influenza vaccine, in children receiving chemotherapy.
    Ottóffy G; Horváth P; Muth L; Sólyom A; Garami M; Kovács G; Nyári T; Molnár D; Pauler G; Jankovics I
    Pediatr Blood Cancer; 2014 Jun; 61(6):1013-6. PubMed ID: 24395342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients.
    Kositanont U; Wongsurakiat P; Pooruk P; Maranetra N; Puthavathana P
    Viral Immunol; 2010 Jun; 23(3):329-34. PubMed ID: 20565296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.